virus
depend
host
cell
obtain
macromolecul
biosynthesi
machineri
requir
replic
order
ensur
undisturb
suppli
element
virus
evolv
plethora
strategi
shape
hostcel
metabol
accord
specif
need
simultan
cours
activ
host
cell
defens
mechan
high
biomolecular
turnov
associ
virion
product
result
highli
anabol
cellular
state
often
accompani
upregul
ingest
extracellular
carbon
sourc
eg
glucos
glutamin
redirect
carbon
suppli
metabol
pathway
crucial
viral
replic
lipogenesi
nucleotid
synthesi
howev
virus
shape
hostcel
metabol
order
obtain
suppli
virion
product
also
induc
reorgan
cellular
membran
biosynthesi
machineri
accompani
alter
lipid
metabol
shall
explain
later
first
insight
depend
virus
certain
carbon
sourc
gain
decad
ago
research
focus
investig
consequ
glucos
glutamin
depriv
viral
replic
howev
avail
mass
spectrometri
ms
base
analysi
metabolom
enabl
fast
progress
toward
indepth
understand
interact
virus
hostcel
metabol
munger
et
al
pioneer
field
show
human
cytomegaloviru
hcmv
highli
depend
extracellular
carbon
also
induc
plethora
alter
hostcel
metabol
requir
proper
replic
msbase
assess
host
cell
metabolom
carbon
flux
sinc
becom
wide
avail
enabl
investig
interact
detail
furthermor
acquir
knowledg
process
enabl
establish
sever
antivir
strategi
exploit
novel
metabol
insight
term
therapi
begun
herein
review
recent
progress
made
toward
understand
interact
virus
hostcel
metabol
also
elabor
strategi
might
result
target
antivir
therapi
member
herpesvirida
probabl
beststudi
group
virus
term
impact
cellular
metabol
herp
simplex
among
first
virus
depend
extracellular
glucos
shown
depriv
glucos
medium
detriment
effect
virion
product
wherea
glutamin
appear
dispens
replic
viru
later
studi
confirm
depend
glucos
glycolysi
inhibitor
also
impair
viral
replic
glucos
analog
impair
function
phosphoglucos
isomeras
thu
result
inhibit
glycolysi
process
glucos
toward
tca
cycl
contrast
downstream
inhibitor
oxam
inhibit
anaerob
glycolysi
abrant
et
al
found
increas
glucos
uptak
lactat
efflux
atp
content
infect
cell
accompani
activ
enhanc
express
ratelimit
enzym
glycolysi
contrast
use
metabolom
screen
vastag
et
al
found
glycolysi
markedli
induc
viru
instead
trigger
anaplerot
glutaminedepend
feed
tca
cycl
enhanc
pyrimidin
synthesi
possibl
explan
could
uptak
glucos
mainli
shift
nucleotid
synthesi
pathway
rather
glycolysi
tca
cycl
underlin
increas
pentos
phosphat
pathway
intermedi
metabolom
analysi
would
explain
high
suscept
viru
nucleotid
analog
treatment
hcmv
anoth
import
member
herpesvirida
famili
caus
signific
morbid
immunosuppress
individu
sinc
metabol
alter
caus
viru
alreadi
extens
review
recent
briefli
discuss
main
find
order
better
delin
concept
differenti
metabol
alter
virus
earli
investig
hint
toward
manipul
hostcel
metabol
hcmv
shown
glucos
uptak
enhanc
infect
cell
first
metabolom
studi
virusinfect
cell
conduct
munger
et
al
author
abl
show
metabolit
glycolysi
tca
cycl
pyrimidin
pathway
increas
upon
infect
accompani
upregul
enzym
involv
pathway
carbon
flux
analysi
delin
increas
glucos
uptak
result
fast
process
glycolysi
tca
cycl
toward
fatti
acid
fa
biosynthesi
expans
pyrimidin
metabolit
pool
found
particular
import
correct
glycosyl
viral
protein
pyrimidin
feed
glycosyl
pathway
via
udpsugar
mechanist
earli
hcmv
gene
express
shown
respons
chang
glycolyt
flux
appear
depend
ca
signal
sinc
calmodulindepend
kinas
kinas
camkk
inhibit
abolish
hcmvinduc
metabol
alter
subsequ
research
highlight
role
ampactiv
protein
kinas
ampk
replic
cycl
hcmv
sinc
kinas
activ
upon
infect
inhibit
detriment
effect
viral
replic
sinc
camkk
known
upstream
ampk
block
camkk
abolish
hcmvinduc
ampk
activ
author
propos
axi
mediat
hcmv
metabol
effect
group
investig
role
glucos
transport
glut
hcmv
infect
found
upregul
express
downregul
follow
infect
chang
glut
express
later
shown
depend
carbohydraterespons
elementbind
protein
chrebp
target
hcmv
infect
apart
appar
need
adequ
glucos
suppli
hcmv
also
depend
extracellular
glutamin
carbon
sourc
depriv
glutamin
extracellular
medium
dampen
hightit
viru
replic
could
restor
addit
tca
cycl
metabolit
thu
point
toward
anaplerot
util
glutamin
hcmv
infect
recent
research
addit
establish
role
viral
protein
upregul
glucos
glutamin
amino
acid
consumpt
mediat
modul
tuber
sclerosi
complex
mtor
independ
epsteinbarr
viru
ebv
caus
infecti
mononucleosi
latent
infect
associ
develop
variou
malign
diseas
latent
infect
cell
found
enhanc
glucos
glutamin
uptak
deregul
glycolysi
chang
describ
induc
ebv
latent
membran
protein
associ
fibroblast
growth
factor
receptor
signal
metabol
alter
specul
play
role
longterm
cancerogen
transform
latent
infect
cell
anoth
viru
herpesvirida
famili
kaposi
sarcomaassoci
herpesviru
kshv
also
shown
broadli
interact
hostcel
metabol
quit
sophist
manner
sanchez
et
al
found
glucos
glutamin
import
earli
viral
replic
gene
translat
respect
furthermor
fa
synthesi
shown
crucial
optim
viru
assembl
matur
yogev
et
al
found
viralencod
microrna
import
induc
alter
glucos
metabol
repress
express
metabol
regul
gene
encod
egl
nine
homolog
encod
protein
mitochondri
result
increas
glycolysi
express
addit
recent
evid
suggest
kshvtransform
cell
critic
depend
extracellular
glutamin
asparagin
enabl
synthesi
fuel
nucleotid
synthesi
accordingli
express
enzym
engag
glutamin
metabol
includ
glutaminas
glutam
dehydrogenas
glutamicoxaloacet
transaminas
need
support
cell
prolifer
kshvtransform
cancer
cell
support
evid
research
group
chandran
abl
demonstr
denovo
latent
kshv
infect
endotheli
cell
b
cell
induc
glutaminas
express
found
partli
cmyc
depend
furthermor
viru
trigger
extracellular
glutam
secret
breakdown
product
glutaminasemedi
enzymat
degrad
glutamin
author
propos
glutam
may
act
autocrin
paracrin
growth
factor
cours
kshvinduc
oncogen
transform
blockad
glutam
secret
inhibit
metabotrop
glutam
receptor
attenu
kshvinfect
cell
prolifer
import
target
within
host
cell
shape
kshv
antivir
respons
andor
kshvinduc
cell
prolifer
includ
hect
domain
ankyrin
repeat
contain
ubiquitin
protein
ligas
heme
group
christofk
perform
pioneer
work
toward
better
understand
adenovirusinduc
host
cell
reprogram
particularli
mechanist
basi
interact
abl
show
viral
product
local
nucleu
bind
transcript
factor
myc
induc
transcript
number
glycolyt
gene
result
enhanc
glycolyt
pathway
activ
nucleotid
product
later
show
myc
regul
glutamin
metabol
adenovirusinfect
cell
glutaminas
critic
enzym
adenoviru
replic
also
true
influenza
coher
inhibit
glutaminas
impair
adenoviru
influenza
replic
dna
virus
discuss
far
induc
glycolysi
andor
increas
glucos
uptak
cours
infect
howev
except
vaccinia
viru
vacv
metabolom
studi
shown
although
viru
affect
glycolyt
flux
highli
depend
glutamin
carbon
sourc
feed
tca
cycl
figur
studi
show
viral
protein
might
respons
effect
stabil
hypoxiainduc
factor
contrast
larg
dna
virus
discuss
found
markedli
differ
mode
metabol
manipul
small
rna
viru
rhinoviru
rv
belong
picornavirida
famili
caus
agent
common
cold
similar
virus
found
enhanc
glucos
uptak
viru
depend
extracellular
glucos
glutamin
optim
viral
replic
howev
amplif
glucos
uptak
detect
fast
h
upon
infect
rule
transcript
control
process
inde
found
enhanc
uptak
revers
phosphoinositid
inhibit
suggest
role
pathway
mediat
rv
effect
contrast
hcmv
infect
found
upregul
express
upon
rv
infect
wherea
express
unaffect
figur
line
concept
upregul
like
mediat
rv
effect
metabolom
studi
reveal
increas
level
metabolit
associ
glycogenolysi
process
describ
far
context
viral
infect
furthermor
found
enhanc
lipogenesi
nucleotid
synthesi
depriv
glutamin
glucos
medium
impair
hightit
rv
replic
earli
glycolysi
inhibitor
potent
inhibit
viral
replic
revers
rvinduc
alter
host
cell
metabolom
thu
find
underlin
potenti
metabol
target
antivir
therapi
state
glutaminas
pivot
import
influenza
viru
replic
furthermor
influenza
viru
shown
depend
extracellular
glucos
viral
replic
could
impair
treatment
glycolysi
inhibitor
contrast
recent
work
found
detriment
effect
surviv
vivo
influenza
infect
attribut
unregul
unfold
protein
respons
absenc
glucos
find
particularli
intrigu
show
metabolismtarget
intervent
effect
cellular
level
might
still
detriment
appli
system
could
thu
affect
plethora
differ
cell
popul
consider
need
taken
account
design
metabolismtarget
antivir
decid
rout
administr
sever
virus
flavivirida
famili
shown
potent
modul
hostcel
metabol
zika
viru
shown
modul
metabol
differ
human
mosquito
cell
wherea
infect
result
enhanc
glucos
util
tca
cycl
human
cell
glucos
util
shift
toward
pentos
phosphat
pathway
mosquito
cell
differ
result
reduct
nucleotid
triphosph
ampkdepend
cell
death
human
cell
dengu
viru
denv
stimul
requir
glycolysi
optim
replic
found
mediat
induct
dehydrogenas
gapdh
viru
nonstructur
protein
distantli
relat
hepat
c
viru
hcv
also
shown
increas
glucos
demand
enhanc
glycolysi
infect
cell
interestingli
hcv
appear
evolv
sever
strategi
target
host
cell
glycolysi
shown
protein
interact
hexokinas
increas
glycolyt
flux
hcvregul
microrna
enhanc
activ
pyruv
kinas
anoth
key
enzym
glycolysi
recent
also
great
progress
elucid
metabol
requir
human
immunodefici
viru
hiv
replic
hollenbaugh
et
al
among
first
studi
metabol
alter
cell
mean
metabolom
intriguingli
abl
show
induc
mark
chang
depend
infect
cell
type
wherea
cell
exhibit
increas
glucos
uptak
metabolit
pool
tca
cycl
opposit
found
infect
macrophag
subsequ
investig
confirm
increas
glucos
uptak
infect
cell
alter
shown
accompani
increas
express
glucos
transport
also
increas
express
key
glucoseprocess
enzym
hexokinas
furthermor
phospholipas
found
crucial
regul
metabol
alter
cell
induc
activ
cmyc
result
activ
transcript
program
led
enhanc
glucos
uptak
nucleotid
biosynthesi
consequ
pharmacolog
inhibit
led
reduct
replic
apart
glucos
glutamin
concentr
found
elev
well
cell
accompani
increas
level
glutaminas
studi
differ
alter
induc
hollenbaugh
et
al
found
although
virus
induc
similar
chang
infect
macrophag
differ
observ
level
quinolin
tryptophan
pathway
compon
anoth
import
studi
hegedu
et
al
found
mark
differ
primari
cell
cell
line
infect
thu
underlin
import
cell
system
studi
cellular
metabolom
take
find
togeth
see
virus
evolv
strategi
alter
central
carbon
suppli
pathway
glucos
glutamin
consumpt
manipul
shown
vital
hightit
viru
replic
apart
virion
product
requir
reorchestr
entir
biosynthesi
machineri
process
usual
involv
reorgan
mani
part
cellular
lipidom
review
next
section
discuss
first
evid
metabol
reprogram
upon
hcmv
infect
provid
munger
et
al
metabol
flux
ms
analys
reveal
hcmv
infect
induc
glucos
flux
directli
fuel
fa
synthesi
munger
research
group
abl
show
hcmv
infect
facilit
mtordepend
proteolyt
cleavag
research
group
provid
addit
evid
cleavag
also
requir
optim
metabol
reprogram
toward
lipogenesi
enabl
hightit
hcmv
replic
studi
inhibit
srebp
proteolyt
cleavag
downstream
target
srebpinduc
lipogenesi
eg
acc
fasn
impair
hcmv
replic
addit
hcmv
infect
induc
express
fa
elongas
elovl
turn
lead
accumul
longchain
verylongchain
fa
vlcfa
shuttl
toward
viral
envelop
product
among
famili
fa
elongas
increas
upon
hcmv
infect
mtorsrebpdepend
manner
remark
inhibit
impair
hcmv
replic
effect
rescu
upon
overexpress
vlcfa
supplement
addit
hcmvinfect
cell
upregul
lowdens
lipoprotein
receptorrel
protein
srebpdepend
manner
interfer
disturb
intracellular
cholesterol
avail
besid
control
lipogenesi
transcript
level
hcmv
also
directli
increas
acc
activ
mention
kshv
infect
induc
transform
host
cell
glucos
glutamin
fatti
acid
metabol
infectioninduc
glycolysi
glutaminolysi
prove
essenti
earli
step
kshv
infect
includ
genom
replic
fatti
acid
synthesi
appear
involv
process
instead
fatti
acid
synthesi
critic
virion
assembl
matur
infecti
particl
sinc
kshvinfect
cell
cultur
presenc
inhibitor
produc
noninfecti
intracellular
virion
evid
provid
research
group
suggest
lipogenesi
requir
kshv
surviv
latent
infect
figur
likewis
perturb
cellular
lipid
metabol
proven
vital
flaviviru
replic
cycl
denv
west
nile
viru
wnv
known
highli
sensit
inhibit
acc
fasn
well
interfer
cholesterol
uptak
homeostasi
biosynthesi
urgent
need
de
novo
lipogenesi
well
chang
intracellular
lipid
distribut
accumul
unsatur
fa
also
propos
essenti
prerequisit
denv
type
infect
gullberg
et
al
identifi
stearoylcoa
desaturas
catalyz
ratelimit
step
format
unsatur
fa
critic
target
regul
composit
intracellular
membran
induc
favor
microenviron
optim
replic
sustain
high
rate
infecti
particl
releas
pharmacolog
inhibit
interrupt
gener
monounsatur
fa
oleic
acid
palmitol
acid
consequ
affect
optim
lipid
membran
composit
membran
fluiditi
lead
decreas
viral
replic
effici
cell
detriment
effect
pharmacolog
inhibit
replic
expand
sever
flavivirida
member
includ
four
denv
serotyp
yellow
fever
viru
yfv
zika
viru
japanes
enceph
viru
jev
therefor
inhibit
acc
fasn
downstream
lipidmodifi
enzym
may
guid
futur
therapi
flaviviru
infect
substanti
find
sever
group
observ
tempor
chang
numer
lipid
speci
especi
phospholipid
upon
hcv
infect
critic
need
de
novo
acc
fasnmedi
fa
synthesi
fuel
viral
replic
recent
metabolom
profil
reveal
unsatur
longchain
fa
oleic
acid
specif
accumul
upon
hcv
infect
accumul
unsatur
fa
may
influenc
membran
composit
fluiditi
hofmann
et
al
demonstr
inhibit
fa
elongas
desaturas
restrict
hcv
replic
studi
treatment
inhibitor
acid
desaturas
impair
hcv
virion
product
possibl
chang
intracellular
membran
composit
virion
assembl
morphogenesi
likewis
liverspecif
inhibitor
propos
antihcv
therapi
follow
proven
efficaci
mice
similarli
inhibit
fasn
reduc
hcv
replic
vitro
evid
suggest
current
use
antihcv
agent
like
ribavirin
inhibit
lipogenesi
side
effect
may
contribut
antivir
properti
mechanist
ribavirin
suppress
express
lipogen
gene
fasn
retinoid
x
receptor
ccaatenhancerbind
protein
manner
statin
anoth
class
drug
use
wide
number
patient
due
cholesterol
lipidlow
properti
exhibit
inhibitori
effect
hcv
replic
probabl
due
inhibit
ratelimit
step
mevalon
pathway
coenzym
reductas
hmgcoa
reductas
lipidom
analysi
also
broaden
understand
regard
metabol
reprogram
ensu
upon
human
coronaviru
hcov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
yan
al
observ
strike
rearrang
cellular
lipid
profil
indic
accumul
fa
satur
unsatur
fa
phospholipid
upon
hcov
infect
author
claim
coronavirida
specif
finetun
host
lipid
profil
achiev
optim
viral
replic
find
corrobor
recent
studi
identifi
pharmacolog
target
srebp
specif
inhibitor
promis
mean
inhibit
merscov
infect
multipl
cell
type
vitro
vivo
inhibit
proteolyt
process
srebp
caus
inhibit
sever
postviralentri
step
includ
reduc
intracellular
lipid
droplet
format
reduc
doubl
membran
vesicl
format
reduc
palmitoyl
viral
protein
potenti
mirror
observ
conclus
made
earlier
yan
et
al
importantli
treatment
also
restrict
srebpdepend
lipogenesi
influenza
cell
result
decreas
palmitoyl
surfac
glycoprotein
hemagglutinin
ultim
impair
replic
similarli
elev
level
multipl
longchain
mono
polyunsatur
fa
associ
rv
infect
discuss
earlier
group
recent
shown
rv
induc
glucos
uptak
feed
anabol
lipogenesi
primari
human
fibroblast
hela
cell
anoth
group
recent
confirm
find
use
lipidom
technolog
primari
human
bronchial
epitheli
cell
differ
time
point
singl
replic
cycl
rv
infect
ie
rang
h
post
infect
accord
data
ngyuen
et
al
observ
accumul
fa
long
acyl
chain
infect
cell
compar
uninfect
control
well
dynam
chang
desatur
statu
fa
pool
within
host
cell
proof
concept
treat
cell
sever
inhibitor
enzym
engag
fa
synthesi
elong
modif
includ
inhibitor
fasn
result
reduct
rv
replic
similarli
inhibit
fasn
novel
potent
inhibitor
decreas
replic
rv
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
hpiv
confirm
essenti
need
fasn
viral
replic
observ
effect
could
rescu
upon
addit
exogen
palmit
acid
altogeth
upstream
interfer
glucos
flux
use
downstream
inhibit
lipogenesi
serv
new
therapeut
target
treat
rv
rsvinduc
respiratori
infect
chikungunya
viru
chikv
infect
fasnmedi
increas
cellular
lipid
pool
result
increas
palmitoyl
viru
nonstructur
protein
three
cystein
residu
zinc
finger
dhhc
domaincontain
palmitoyltransferas
palmitoyl
critic
chikv
replic
sinc
orchestr
cap
viru
rna
therefor
chikv
induct
anabol
lipid
synthesi
via
fasn
host
cell
gener
adequ
substrat
suppli
proper
function
intracellular
palmitoyltransferas
confirm
observ
inhibit
fasn
shown
impair
chikv
replic
could
rescu
upon
exogen
palmit
acid
suppli
last
induct
fasn
also
observ
upon
infect
translat
increas
intracellular
palmit
oleic
stearic
acid
pool
although
author
abl
delin
de
novosynthes
lipid
fuel
replic
show
fasn
exclus
requir
late
stage
viral
replic
cycl
indic
role
fasn
viral
bud
posttransl
modif
structur
protein
gag
protein
line
exist
evid
propos
essenti
role
sever
posttransl
lipid
modif
structur
protein
henc
life
cycl
virus
close
link
composit
cellular
lipidom
defin
viral
cellular
membran
composit
macromolecul
synthesi
posttranscript
modif
viral
protein
order
ensur
suffici
substrat
suppli
enabl
optim
replic
viral
particl
virus
exploit
host
transcript
factor
coopt
sever
enzym
engag
de
novo
lipid
synthesi
process
aforement
line
evid
suggest
lipidbas
antivir
strategi
may
guid
futur
antivir
therapi
particular
inhibit
srebp
cleavag
target
famodifi
enzym
eg
fa
elongas
desaturas
repres
promis
target
broadspectrum
antivir
metabol
intervent
howev
vivo
relev
viru
lipid
interact
yet
determin
studi
urgent
need
better
understand
process
elabor
variou
form
viru
interfer
host
cellular
metabolom
seen
although
mani
induc
chang
follow
similar
pattern
differ
virus
distinct
virusspecif
fingerprint
nonetheless
found
viru
mirror
need
respect
pathogen
specif
molecular
compound
process
replic
notwithstand
knowledg
field
consist
phenotyp
character
impact
infect
central
pathway
hostcel
metabol
wherea
understand
mechanist
basi
chang
far
limit
seen
virus
develop
strategi
divers
activ
cytosol
signal
eg
activ
transcript
regul
eg
activ
myc
chrebp
srebp
current
data
point
toward
dichotomi
dna
rna
virus
look
respect
strategi
host
cell
manipul
wherea
transcript
control
key
metabol
pathway
found
sever
dna
virus
rna
virus
appear
shape
hostcel
metabol
via
posttranscript
modif
line
pace
respect
replic
cycl
summar
tabl
knowledg
specif
alter
induc
given
viru
result
numer
strategi
target
viral
replic
high
efficaci
cell
cultur
vivo
model
howev
mani
establish
target
metabolismmanipul
antivir
central
enzym
cellular
metabol
futur
research
elabor
whether
mention
strategi
translat
clinic
applic
without
caus
major
harm
unaffect
host
cell
particular
appear
promis
compound
given
wellestablish
favor
sideeffect
profil
undoubtedli
research
dynam
area
help
deepen
understand
interact
might
result
addit
way
impair
viral
replic
mean
metabol
intervent
instanc
still
major
blind
spot
particularli
understand
mechanist
basi
rna
virusinduc
alter
cellular
metabol
furthermor
littl
research
role
pattern
recognit
context
abovement
adapt
addit
mani
find
report
herein
gener
context
highli
specif
cellular
model
differenti
modul
differ
target
cell
eg
prolifer
cell
might
result
advers
observ
still
limit
knowledg
role
metabol
pathogenesi
plethora
pathogen
virus
requir
research
insight
question
help
us
greatli
advanc
understand
crucial
interact
might
sharpen
therapeut
arsen
target
viral
achil
heel
gg
js
list
inventor
patent
concern
antivir
agent
rhinoviru
infect
remain
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
